ZA919938B - Short peptides with insulin activity - Google Patents
Short peptides with insulin activityInfo
- Publication number
- ZA919938B ZA919938B ZA919938A ZA919938A ZA919938B ZA 919938 B ZA919938 B ZA 919938B ZA 919938 A ZA919938 A ZA 919938A ZA 919938 A ZA919938 A ZA 919938A ZA 919938 B ZA919938 B ZA 919938B
- Authority
- ZA
- South Africa
- Prior art keywords
- amino acid
- short peptides
- covalent bond
- insulin activity
- formula
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000000539 dimer Substances 0.000 abstract 1
- 229910052739 hydrogen Chemical group 0.000 abstract 1
- 239000001257 hydrogen Chemical group 0.000 abstract 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4040574 | 1990-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA919938B true ZA919938B (en) | 1992-09-30 |
Family
ID=6420676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA919938A ZA919938B (en) | 1990-12-19 | 1991-12-18 | Short peptides with insulin activity |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5461035A (OSRAM) |
| EP (1) | EP0491361B1 (OSRAM) |
| JP (2) | JP3378588B2 (OSRAM) |
| KR (1) | KR100237948B1 (OSRAM) |
| AT (1) | ATE177753T1 (OSRAM) |
| AU (1) | AU643349B2 (OSRAM) |
| CA (1) | CA2058020C (OSRAM) |
| CZ (1) | CZ284568B6 (OSRAM) |
| DE (1) | DE59109109D1 (OSRAM) |
| DK (1) | DK0491361T3 (OSRAM) |
| ES (1) | ES2130130T3 (OSRAM) |
| FI (1) | FI105816B (OSRAM) |
| GR (1) | GR3030510T3 (OSRAM) |
| HR (1) | HRP940839B1 (OSRAM) |
| HU (1) | HU222493B1 (OSRAM) |
| IE (1) | IE914408A1 (OSRAM) |
| IL (1) | IL100400A (OSRAM) |
| NO (1) | NO308951B1 (OSRAM) |
| NZ (1) | NZ241029A (OSRAM) |
| PT (1) | PT99850B (OSRAM) |
| SK (2) | SK282361B6 (OSRAM) |
| TW (1) | TW227004B (OSRAM) |
| YU (1) | YU189891A (OSRAM) |
| ZA (1) | ZA919938B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0545198B1 (de) * | 1991-11-29 | 1999-09-15 | Hoechst Aktiengesellschaft | Peptide mit insulinartiger Wirkung |
| SE0002716L (sv) * | 2000-07-18 | 2002-01-19 | Lars Wahlberg | Komposition mot insekter |
| ATE298662T1 (de) * | 2001-01-15 | 2005-07-15 | Michelin Soc Tech | Formgebungstrommel für die reifenherstellung |
| US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| KR101909052B1 (ko) * | 2017-02-09 | 2018-10-17 | 강원대학교산학협력단 | 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2740406A1 (de) * | 1977-09-08 | 1979-03-22 | Hoechst Ag | Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung |
| DE2801175A1 (de) * | 1978-01-12 | 1979-07-19 | Hoechst Ag | Verfahren zur herstellung cysteinhaltiger peptide |
| DD147942A1 (de) * | 1979-08-20 | 1981-04-29 | Guenter Losse | Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung |
| FR2525592B1 (OSRAM) * | 1982-04-26 | 1984-09-14 | Pasteur Institut |
-
1991
- 1991-11-28 TW TW080109358A patent/TW227004B/zh not_active IP Right Cessation
- 1991-12-06 YU YU189891A patent/YU189891A/sh unknown
- 1991-12-17 FI FI915933A patent/FI105816B/fi active
- 1991-12-17 ES ES91121624T patent/ES2130130T3/es not_active Expired - Lifetime
- 1991-12-17 EP EP91121624A patent/EP0491361B1/de not_active Expired - Lifetime
- 1991-12-17 AT AT91121624T patent/ATE177753T1/de not_active IP Right Cessation
- 1991-12-17 DE DE59109109T patent/DE59109109D1/de not_active Expired - Lifetime
- 1991-12-17 DK DK91121624T patent/DK0491361T3/da active
- 1991-12-17 IL IL100400A patent/IL100400A/en not_active IP Right Cessation
- 1991-12-17 NZ NZ241029A patent/NZ241029A/xx not_active IP Right Cessation
- 1991-12-18 AU AU89825/91A patent/AU643349B2/en not_active Expired
- 1991-12-18 IE IE440891A patent/IE914408A1/en not_active IP Right Cessation
- 1991-12-18 CZ CS913879A patent/CZ284568B6/cs not_active IP Right Cessation
- 1991-12-18 JP JP33475591A patent/JP3378588B2/ja not_active Expired - Lifetime
- 1991-12-18 HU HU9104009A patent/HU222493B1/hu active IP Right Grant
- 1991-12-18 SK SK232-2001A patent/SK282361B6/sk not_active IP Right Cessation
- 1991-12-18 ZA ZA919938A patent/ZA919938B/xx unknown
- 1991-12-18 KR KR1019910023282A patent/KR100237948B1/ko not_active Expired - Lifetime
- 1991-12-18 CA CA002058020A patent/CA2058020C/en not_active Expired - Lifetime
- 1991-12-18 SK SK3879-91A patent/SK282360B6/sk not_active IP Right Cessation
- 1991-12-18 PT PT99850A patent/PT99850B/pt not_active IP Right Cessation
- 1991-12-18 NO NO914999A patent/NO308951B1/no not_active IP Right Cessation
-
1994
- 1994-08-04 US US08/285,443 patent/US5461035A/en not_active Expired - Lifetime
- 1994-10-26 HR HRP-1898/91A patent/HRP940839B1/xx not_active IP Right Cessation
-
1999
- 1999-06-15 GR GR990401585T patent/GR3030510T3/el unknown
-
2002
- 2002-10-02 JP JP2002289401A patent/JP3802863B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU630951B2 (en) | Enzymatic removal of a protein amino-terminal sequence | |
| AU1563588A (en) | Pasteurizable, freeze-driable hemoglobin-based blood substitute | |
| SG52690A1 (en) | Process for the production of biologically active protein (e.g. tgf) | |
| HUT52548A (en) | Process for production of mini-proinsuline and medical compositions containing them as active substance | |
| DK642587D0 (da) | Insulinpraeparat | |
| MY102806A (en) | Human interleukin-3 and muteins thereof | |
| HUT66437A (en) | A composition used as a therapeutic agent against chronic viral hepatic diseases | |
| ATE130312T1 (de) | Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen. | |
| FI892185A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi | |
| IL100400A0 (en) | Short peptides with insulin activity | |
| AU2308992A (en) | Cysteine depleted il-6 muteins | |
| AU2002307510A1 (en) | Cytokine protein family | |
| HU895788D0 (en) | Process for producing peptides and medical products containing them | |
| HUT50195A (en) | New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions | |
| AU3902489A (en) | Non-glycosylated, recombinant human IL2 in the reduced form, the process for obtaining it and its use as a medicament | |
| AU6860294A (en) | New chondrocyte proteins | |
| AU542310B2 (en) | Glicentin related purified peptide having 30 amino acids | |
| DE69203098D1 (de) | Verwendung eines Polypeptids mit humaner Interleukin-2 Aktivität zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Pneumothoraxen. |